Treatment with gonadotropins like hCG and FSH promotes testicular growth and spermatogenesis in adolescent boys with congenital hypogonadotropic hypogonadism (CHH), unlike testosterone therapy. This evidence concerns the gene BRD2 and cartilage-hair hypoplasia.